| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
Center for Reproductive Sciences Department of Obstetrics, Gynecology and Reproductive Sciences University of California School of Medicine San Francisco, California 94143
We asked whether the antiangiogenic action of 16K human PRL (hPRL), in addition to blocking mitogen-induced vascular endothelial cell proliferation, involved activation of programmed cell death. Treatment with recombinant 16K hPRL increased DNA fragmentation in cultured bovine brain capillary endothelial (BBE) and human umbilical vein endothelial (HUVE) cells in a time- and dose-dependent fashion, independent of the serum concentration. The activation of apoptosis by 16K hPRL was specific for endothelial cells, and the activity of the peptide could be inhibited by heat denaturation, trypsin digestion, and immunoneutralization, but not by treatment with the endotoxin blocker, polymyxin-B. 16K hPRL-induced apoptosis was correlated with the rapid activation of caspases 1 and 3 and was blocked by pharmacological inhibition of caspase activity. Caspase activation was followed by inactivation of two caspase substrates, poly(ADP-ribose) polymerase (PARP) and the inhibitor of caspase-activated deoxyribonuclease (DNase) (ICAD). Furthermore, 16K hPRL increased the conversion of Bcl-X to its proapoptotic form, suggesting that the Bcl-2 protein family may also be involved in 16K hPRL-induced apoptosis. These findings support the hypothesis that the antiangiogenic action of 16K hPRL includes the activation of programmed cell death of vascular endothelial cells.
This article has been cited by other articles:
 |
|
 |
|
  M. E. Cruz-Soto, G. Cosio, M. C. Jeziorski, V. Vargas-Barroso, M. B. Aguilar, A. Carabez, P. Berger, P. Saftig, E. Arnold, S. Thebault, et al. Cathepsin D Is the Primary Protease for the Generation of Adenohypophyseal Vasoinhibins: Cleavage Occurs within the Prolactin Secretory Granules Endocrinology, December 1, 2009; 150(12): 5446 - 5454. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Clapp, S. Thebault, M. C. Jeziorski, and G. Martinez De La Escalera Peptide Hormone Regulation of Angiogenesis Physiol Rev, October 1, 2009; 89(4): 1177 - 1215. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 C. Clapp, S. Thebault, E. Arnold, C. Garcia, J. C. Rivera, and G. M. de la Escalera Vasoinhibins: novel inhibitors of ocular angiogenesis Am J Physiol Endocrinol Metab, October 1, 2008; 295(4): E772 - E778. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 G. Ge, C. A. Fernandez, M. A. Moses, and D. S. Greenspan Bone morphogenetic protein 1 processes prolactin to a 17-kDa antiangiogenic factor PNAS, June 12, 2007; 104(24): 10010 - 10015. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. P. Tabruyn, C. Sabatel, N.-Q.-N. Nguyen, C. Verhaeghe, K. Castermans, L. Malvaux, A. W. Griffioen, J. A. Martial, and I. Struman The Angiostatic 16K Human Prolactin Overcomes Endothelial Cell Anergy and Promotes Leukocyte Infiltration via Nuclear Factor-{kappa}B Activation Mol. Endocrinol., June 1, 2007; 21(6): 1422 - 1429. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N.-Q.-N. Nguyen, S. P. Tabruyn, L. Lins, M. Lion, A. M. Cornet, F. Lair, F. Rentier-Delrue, R. Brasseur, J. A. Martial, and I. Struman Prolactin/growth hormone-derived antiangiogenic peptides highlight a potential role of tilted peptides in angiogenesis PNAS, September 26, 2006; 103(39): 14319 - 14324. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 Y. Macotela, M. B. Aguilar, J. Guzman-Morales, J. C. Rivera, C. Zermeno, F. Lopez-Barrera, G. Nava, C. Lavalle, G. M. de la Escalera, and C. Clapp Matrix metalloproteases from chondrocytes generate an antiangiogenic 16 kDa prolactin J. Cell Sci., May 1, 2006; 119(9): 1790 - 1800. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S.-h. Lee, M. Nishino, T. Mazumdar, G. E. Garcia, M. Galfione, F. L. Lee, C. L. Lee, A. Liang, J. Kim, L. Feng, et al. 16-kDa Prolactin Down-Regulates Inducible Nitric Oxide Synthase Expression through Inhibition of the Signal Transducer and Activator of Transcription 1/IFN Regulatory Factor-1 Pathway Cancer Res., September 1, 2005; 65(17): 7984 - 7992. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J. Aranda, J. C. Rivera, M. C. Jeziorski, J. Riesgo-Escovar, G. Nava, F. Lopez-Barrera, H. Quiroz-Mercado, P. Berger, G. Martinez de la Escalera, and C. Clapp Prolactins Are Natural Inhibitors of Angiogenesis in the Retina Invest. Ophthalmol. Vis. Sci., August 1, 2005; 46(8): 2947 - 2953. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Tabruyn, N.-Q.-N. Nguyen, A. M. Cornet, J. A. Martial, and I. Struman The Antiangiogenic Factor, 16-kDa Human Prolactin, Induces Endothelial Cell Cycle Arrest by Acting at Both the G0-G1 and the G2-M Phases Mol. Endocrinol., July 1, 2005; 19(7): 1932 - 1942. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K Horiguchi, S Yagi, K Ono, Y Nishiura, M Tanaka, M Ishida, and T Harigaya Prolactin gene expression in mouse spleen helper T cells J. Endocrinol., December 1, 2004; 183(3): 639 - 646. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. Gonzalez, A. M. Corbacho, J. P. Eiserich, C. Garcia, F. Lopez-Barrera, V. Morales-Tlalpan, A. Barajas-Espinosa, M. Diaz-Munoz, R. Rubio, S.-H. Lin, et al. 16K-Prolactin Inhibits Activation of Endothelial Nitric Oxide Synthase, Intracellular Calcium Mobilization, and Endothelium-Dependent Vasorelaxation Endocrinology, December 1, 2004; 145(12): 5714 - 5722. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Lkhider, R. Castino, E. Bouguyon, C. Isidoro, and M. Ollivier-Bousquet Cathepsin D released by lactating rat mammary epithelial cells is involved in prolactin cleavage under physiological conditions J. Cell Sci., October 1, 2004; 117(21): 5155 - 5164. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
D. Piwnica, P. Touraine, I. Struman, S. Tabruyn, G. Bolbach, C. Clapp, J. A. Martial, P. A. Kelly, and V. Goffin Cathepsin D Processes Human Prolactin into Multiple 16K-Like N-Terminal Fragments: Study of Their Antiangiogenic Properties and Physiological Relevance Mol. Endocrinol., October 1, 2004; 18(10): 2522 - 2542. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Z. Duenas, J. C. Rivera, H. Quiroz-Mercado, J. Aranda, Y. Macotela, P. M. de Oca, F. Lopez-Barrera, G. Nava, J. L. Guerrero, A. Suarez, et al. Prolactin in Eyes of Patients with Retinopathy of Prematurity: Implications for Vascular Regression Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2049 - 2055. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
H. Pan, N.-Q.-N. Nguyen, H. Yoshida, F. Bentzien, L. C. Shaw, F. Rentier-Delrue, J. A. Martial, R. Weiner, I. Struman, and M. B. Grant Molecular Targeting of Antiangiogenic Factor 16K hPRL Inhibits Oxygen-Induced Retinopathy in Mice Invest. Ophthalmol. Vis. Sci., July 1, 2004; 45(7): 2413 - 2419. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 S. Takiguchi, N. Sugino, K. Esato, A. Karube-Harada, A. Sakata, Y. Nakamura, H. Ishikawa, and H. Kato Differential Regulation of Apoptosis in the Corpus Luteum of Pregnancy and Newly Formed Corpus Luteum after Parturition in Rats Biol Reprod, February 1, 2004; 70(2): 313 - 318. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 B. Musicki, G. J. Pepe, and E. D. Albrecht Functional Differentiation of the Placental Syncytiotrophoblast: Effect of Estrogen on Chorionic Somatomammotropin Expression during Early Primate Pregnancy J. Clin. Endocrinol. Metab., September 1, 2003; 88(9): 4316 - 4323. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
S. P. Tabruyn, C. M. Sorlet, F. Rentier-Delrue, V. Bours, R. I. Weiner, J. A. Martial, and I. Struman The Antiangiogenic Factor 16K Human Prolactin Induces Caspase-Dependent Apoptosis by a Mechanism that Requires Activation of Nuclear Factor-{kappa}B Mol. Endocrinol., September 1, 2003; 17(9): 1815 - 1823. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Kim, W. Luo, D.-T. Chen, K. Earley, J. Tunstead, L.-Y. Yu-Lee, and S.-H. Lin Antitumor Activity of the 16-kDa Prolactin Fragment in Prostate Cancer Cancer Res., January 15, 2003; 63(2): 386 - 393. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Bentzien, I. Struman, J.-F. Martini, J. Martial, and R. Weiner Expression of the Antiangiogenic Factor 16K hPRL in Human HCT116 Colon Cancer Cells Inhibits Tumor Growth in Rag1-/- Mice Cancer Res., October 1, 2001; 61(19): 7356 - 7362. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Endocrinology | Endocrine Reviews | J. Clin. End. & Metab. |
| Molecular Endocrinology | Recent Prog. Horm. Res. | All Endocrine Journals |
